Therapeutic implication of HER2 in advanced biliary tract cancer
Ah‐Rong Nam(Seoul National University), Yung‐Jue Bang(Seoul National University Hospital)
Cited by 86
Related Papers
Histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), enhances anti-tumor effects of the poly (ADP-ribose) polymerase (PARP) inhibitor olaparib in triple-negative breast cancer cells
|Breast Cancer Research|2015|176
Therapeutic Targeting of the DNA Damage Response Using an ATR Inhibitor in Biliary Tract Cancer
|Cancer Research and Treatment|2018|31
Inhibition of ATR Increases the Sensitivity to WEE1 Inhibitor in Biliary Tract Cancer
|Cancer Research and Treatment|2020|21
TDP1 and TOP1 Modulation in Olaparib-Resistant Cancer Determines the Efficacy of Subsequent Chemotherapy
|Cancers|2020|8
YAP as a therapeutic target to reverse trastuzumab resistance
|Gastric Cancer|2025|0